CODACCI PISANELLI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 3.340
EU - Europa 996
AS - Asia 487
AF - Africa 43
SA - Sud America 23
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.892
Nazione #
US - Stati Uniti d'America 3.296
IT - Italia 218
SE - Svezia 205
UA - Ucraina 188
SG - Singapore 177
IN - India 167
DE - Germania 114
FI - Finlandia 101
CN - Cina 91
CA - Canada 40
GB - Regno Unito 34
FR - Francia 28
IE - Irlanda 27
TG - Togo 27
AR - Argentina 19
BG - Bulgaria 18
ID - Indonesia 16
RU - Federazione Russa 15
EG - Egitto 11
RO - Romania 11
BE - Belgio 10
ES - Italia 9
PH - Filippine 7
NL - Olanda 6
PT - Portogallo 6
TW - Taiwan 6
IR - Iran 5
BR - Brasile 4
MX - Messico 3
MY - Malesia 3
SA - Arabia Saudita 3
TR - Turchia 3
GR - Grecia 2
HK - Hong Kong 2
JO - Giordania 2
MA - Marocco 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
Totale 4.892
Città #
Fairfield 569
Woodbridge 320
Ashburn 280
Houston 269
Seattle 205
Cambridge 202
Ann Arbor 182
Wilmington 174
Chandler 139
Princeton 116
Singapore 114
Plano 83
Rome 82
Jacksonville 74
San Paolo di Civitate 70
Beijing 64
Lawrence 64
San Diego 51
Boston 48
Millbury 42
Santa Clara 37
Dublin 27
Lomé 27
Andover 24
Bremen 23
Lappeenranta 23
Federal 19
Sofia 18
Ottawa 17
Los Angeles 16
Norwalk 15
Toronto 15
Jakarta 14
San Mateo 12
Boardman 11
Bühl 11
Falls Church 11
New York 10
Brussels 9
Bolzano Vicentino 8
Des Moines 8
Cairo 5
Falkenstein 5
Fasano 5
Fremont 5
Indiana 5
Mannheim 5
Phoenix 5
Shanghai 5
Southend 5
Braga 4
Buffalo 4
Helsinki 4
Kunming 4
London 4
Nanjing 4
San Pablo City 4
Amsterdam 3
Dearborn 3
Hagen 3
Istanbul 3
Leander 3
Milan 3
Rio de Janeiro 3
Ta'if 3
Templecombe 3
Amman 2
Angeles City 2
Athens 2
Barcelona 2
Bengaluru 2
Cascais 2
El Jadida 2
Elora 2
Frankfurt am Main 2
Hong Kong 2
Iasi 2
Mexico City 2
Muizenberg 2
Munich 2
New Orleans 2
Passau 2
Prescot 2
Provo 2
Pune 2
Québec 2
Rocca Priora 2
Saskatoon 2
Shah Alam 2
Surabaya 2
Taichung 2
Taranto 2
Yellow Springs 2
Almaty 1
Antwerp 1
Arnsberg 1
Auburn Hills 1
Auckland 1
Bad Bellingen 1
Benito Juarez 1
Totale 3.664
Nome #
Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors 110
Chemotherapy and radiotherapy for anal canal carcinoma 94
Evaluation of the relation between radionucleotide fractional incorporation and in vitro chemosensitivity of colorectal tumors 93
arsenical c-glucoside derivatives with promising antitumor activity 88
Cancer. The word raises panic in patients and medics 87
Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? 83
Epigenetic treatment of solid tumours. A review of clinical trials 83
Breast cancer during pregnancy 82
Current role and safety profile of aromatase inhibitors in early breast cancer 81
Breast cancer risk of hormonal contraception. Counselling considering new evidence 75
Whole body MRI for systemic staging of breast cancer in pregnant women 74
The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site 73
Attitudes on fertility issues in breast cancer patients. An Italian survey 72
An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint 71
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parameters 71
Solitary plasmacytoma of tibia: A possible correlation with younger age 70
Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastases 69
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma 69
5-Fluorouracil (FU) with folinic acid (FA) and Mitomycin c (MMC)in the adjuvant treatment of colorectal carcinoma. Part II. Evaluation of toxicity. 69
Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice 68
Thymidylate synthase and drug resistance. 67
ELEVATED DOSES OF CARMUSTINE AND MITOMYCIN-C, WITH LONIDAMINE ENHANCEMENT AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER - RESULTS FROM A PILOT-STUDY 67
Breastfeeding during R-CHOP chemotherapy. Please abstain! 66
A new anthracycline regimen for prolymphocytic leukemia? Study of a case report with flow cytometric implications. 66
Pre-operative Radio-Chemotherapy of Rectal Cancer: Toxicity and Preliminary Results with the Addition of Weekly Oxaliplatin 65
High-dose chemotherapy with bone marrow transplantation for advanced colorectal carcer: report on toxicity 65
The only thing I know is that I know nothing": 5-fluorouracil in human milk 64
K-ras mutations and cetuximab in colorectal cancer 63
Scientific method: Statistical errors - discussion 63
TFAP2E-DKK4 and chemoresistance in colorectal cancer. 61
Clinical course and phenotypic instability in 4 cases of multiple myeloma: a biological model of tumors 60
COMPARATIVE IN VITRO AND IN VIVO STUDY OF A NITROXYL DERIVATIVE OF 5-FLUOROURACIL (MAGNIZIL) ON HUMAN GASTROINTESTINAL TUMORS 60
PHARMACOKINETICS OF BOLUS 5-FLUOROURACIL: RELATIONSHIP BETWEEN DOSE, PLASMA CONCENTRATIONS, AREA-UNDER-THE-CURVE AND TOXICITY. 58
Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin. 58
Comparison of continuous infusions and bolus injections of 5-fluorouracil with or without leucovorin: implications for inhibition of thymidylate synthase 57
IS THERAPY WITH CYTOSTATICS OBSOLETE IN HAIRY-CELL LEUKEMIA 57
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity 57
Breast cancer risk after exposure to fertility drugs 56
Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients 56
The pros and comms of gene sequencing 56
High-dose chemotherapy with autologous bone marrow transplantation, in the treatment of Advanced colorectal cancer. 54
Effect of epoetin on survival in patients with breast cancer 54
Cell-free circulating tumor DNA(ctDNA) analysis by next generation sequencing(NGS) panel in non small cell lung cancer patients(NSCLC): implications in clinical practice. XX Congresso Nazionale AIOM 2018 (Poster D18) 54
Chemotherapy and Target Therapy in the Management of Adult High-Grade Gliomas 54
Chemotherapy and Immunotherapy in Metastatic Colorectal Cancer 53
High-dose 5-Fluorouracil with uridine-diphosphoglucose rescue increases thymidylate synthase inhibition but not 5-Fluorouracil incorporation into RNA in murine tumors. 53
Hodgkin lymphoma in pregnancy. Good news for clinicians and women 53
Bringing greater accuracy to Europe's Healthcare Systems. The unexploited potential of biomarker testing in oncology 53
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences 52
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation 51
Is biopsy for unresectable pancreatic cancer always necessary ? 51
Managing ovarian tumors during pregnancy 51
CHANGES IN CARACHTERISTICS OF PATIENTS DIAGNOSED WITH MELANOMA, IDI-IRCCS, ROME, 1992-2000 50
Cytosine arabinoside-induced differentiation and killing: Unresolved questions 50
Preoperative radio-chemotherapy of rectal cancer: toxicity and preliminary results with the addition of weekly oxaliplatin 50
DOSE-INTENSE 5-FLUOROURACIL IN COLORECTAL-CANCER 50
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. 49
Intravesical administration of gemcitabine in superficial bladder cancer: A phase I study with pharmacodynamic evaluation. A phase II study with chemoresection of the marker lesion 49
Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target! 48
The AACR 2013 in Washington D.C. 48
Have we reached a plateau in adjuvant breast cancer therapy? 48
High-dose chemotherapy + ABMT in advaced colorectal carcinoma: different response of hepatic and extra-hepatic metastases. 47
Effect of Ruboxil (nitroxyl derivative of daunomicin) on hepatic metastases of colorectal carcinoma 47
Surveillance for Recurrence of Colorectal Cancer 47
Intra-articular methotrexate in the therapy of rheumatoid arthritis 46
Bringing onco‐innovation to Europe’s healthcare systems. The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine 46
Studio in vitro sulla chemiosensibilità dei tumori primitivi e metastatici del retto-colon. 45
The PSA position - comment #28639 45
Treatment of brain metastases in ALK-positive non-small cell lung cancer 45
The effect of COVID-19 pandemic on daily oncology clinical practice 44
Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution 43
Propelling healthcare with advanced therapy medicinal products. A policy discussion 42
Cancer in pregnancy. An association to make one shiver-highlights from 'Cancer in pregnancy. 15 years after', 10-11 October 2019, Milan, Italy 39
In vitro effect of a nitroxyl-derivative of Daunorubicin (Ruboxyl) on colo-rectal cancer. 38
ANTHRACYCLINE IN COLORECTAL-CARCINOMA - AN INVITRO SHORT-TERM ASSAY TO PREDICT DRUG SENSITIVITY - PRELIMINARY-RESULTS 38
Epigenetic targets in the treatment of cancer 38
Lactation during and after breast cancer 37
Preclinical and clinical studies of chemotherapeutic strategies in colorectal cancer patients 35
Modulation of 5-fluorouracil in mice using uridine diphosphoglucose 33
KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 31
What's wrong with early diagnosis of breast cancer in young women? 29
Medical treatment of early stage and rare histological variants of epithelial ovarian cancer 29
Role of vacuum assisted biopsy(mammotome) in early detection of breast cancer 29
5-fluorouracil modulation in the chemotherapy of colorectal cancer. 27
First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother. A case study 27
Pregnancy and lactation. Risk or protective factors for breast cancer? 27
How a chairty oversells mammography - reply 26
The impact of cytokines circulating levels on cancer-related-fatigue 25
Letter to the Editor - DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 25
Development of a lambda chain synthesyzing clone during the course of a non producer myeloma. 24
Somministrazione endovescicale di Gemcitabina: studio di fase I con valutazione farmacodinamica, studio di fase II con valutazione di lesione marker. 23
MODULATION OF CONTINUOUS INFUSION 5-FLUOROURACIL (5FU) WITH WEEKLY METHOTREXATE (MTX) 21
Famiglia di molecole a base di zuccheri ad uso terapeutico e relativo procedimento di produzioneE 20
Improving care and reducing costs in oncology. 19
Review article a multidisciplinary evaluation for advanced supportive care of breast cancer patients 11
In vitro evaluation of drugs active in colorectal carcinoma therapy: A preliminary study in view of the clinical use of chemosensitivity tests 8
Totale 5.035
Categoria #
all - tutte 14.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 85
selected - selezionate 0
volume - volumi 0
Totale 14.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020721 0 0 0 0 0 117 132 136 113 96 88 39
2020/2021463 61 50 14 30 11 27 6 33 35 100 77 19
2021/2022881 9 55 101 28 122 24 21 106 61 69 106 179
2022/2023818 197 203 44 87 78 76 9 26 63 10 19 6
2023/2024417 41 48 16 24 27 49 30 19 1 82 37 43
2024/2025230 33 25 57 34 58 23 0 0 0 0 0 0
Totale 5.035